Stock A241820 PCL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company PCL, Inc.

Equities

A241820

KR7241820000

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
1,201 KRW -0.25% Intraday chart for PCL, Inc. -1.40% -66.50%
Jan. 16 PCL, Inc. announced that it has received KRW 9.99999885 billion in funding from Global Emerging Markets CI
2023 PCL, Inc. announced that it has received KRW 9.99999838 billion in funding from Global Emerging Markets CI

Business Summary

PCL Inc. is a Korea-based company principally engaged in development and manufacture of vitro diagnostic medical device for immunological diagnosis. The Company’s products include blood bank screening products and quick diagnostic products. And the Company also provides platform services.

Number of employees: 35

Sales per Business

KRW in Million2022Weight2023Weight Delta
Diagnostic Medicines Products
97.9 %
37,176 99.9 % 8,254 97.9 % -77.80%
Other
1.8 %
6 0.0 % 150 1.8 % +2,610.03%
Rental and Sublease Rental Income
0.2 %
- - 20 0.2 % -
Diagnostic Medicines Merchandise
0.1 %
36 0.1 % 5 0.1 % -84.61%

Sales per region

KRW in Million2022Weight2023Weight Delta
Asia
45.9 %
-- 3,866 45.9 % -
South Korea
34.7 %
28,134 75.6 % 2,922 34.7 % -89.61%
Europe
17.6 %
-- 1,484 17.6 % -
Others
1.6 %
-- 138 1.6 % -
Global
0.2 %
-- 20 0.2 % -

Managers

Managers TitleAgeSince
So-Yeon Kim CEO
 Chief Executive Officer 53 -
Seung-Ki Hong AUD
 Comptroller/Controller/Auditor 70 -

Members of the board

Members of the board TitleAgeSince
Mahn-Soon Hwang BRD
 Director/Board Member 54 -
Chul-Joon Kim BRD
 Director/Board Member 71 -
So-Yeon Kim CEO
 Chief Executive Officer 53 -
Yang-Soo Kim BRD
 Director/Board Member 45 -
Hyeok-Jae Song BRD
 Director/Board Member 51 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 54,038,118 33,251,622 ( 61.53 %) 0 61.53 %

Shareholders

NameEquities%Valuation
So-Yeon Kim
18.51 %
10,002,144 18.51 % 11 M ₩
OLIX PHARMACEUTICALS, INC
7.648 %
4,132,665 7.648 % 4 M ₩
Dong-gi Lee
1.232 %
666,001 1.232 % 721 286 ₩
ST No. 29 New Tech Investment Association
0.6852 %
370,257 0.6852 % 400 992 ₩
In-gyu Kim
0.4441 %
240,000 0.4441 % 259 922 ₩
Ji-won Lee
0.1155 %
62,394 0.1155 % 67 573 ₩
Seung-hyun Lee
0.1155 %
62,394 0.1155 % 67 573 ₩

Company contact information

PCL, Inc.

99 Digital-ro 9-gil Rm 701, Star Valley

08510, Seoul

+

http://www.pclchip.com
address PCL, Inc.(A241820)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Diagnostics & Testing

Sales per Business

Sales per region

Sector Bio Diagnostics & Testing

1st Jan change Capi.
PCL, INC. Stock PCL, Inc.
-66.50% 47.15M
EXACT SCIENCES CORPORATION Stock Exact Sciences Corporation
-20.45% 10.82B
IOVANCE BIOTHERAPEUTICS, INC. Stock Iovance Biotherapeutics, Inc.
+43.17% 3.25B
GUARDANT HEALTH, INC. Stock Guardant Health, Inc.
-35.86% 2.11B
BGI GENOMICS CO., LTD. Stock BGI Genomics Co., Ltd.
-17.21% 2.08B
VERACYTE, INC. Stock Veracyte, Inc.
-29.81% 1.48B
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock Maravai LifeSciences Holdings, Inc.
+17.56% 1.02B
SEEGENE, INC. Stock Seegene, Inc.
-4.37% 733M
CAREDX, INC Stock CareDx, Inc
-37.00% 391M
ADAPTIVE BIOTECHNOLOGIES CORPORATION Stock Adaptive Biotechnologies Corporation
-46.94% 377M
Bio Diagnostics & Testing
  1. Stock Market
  2. Equities
  3. A241820 Stock
  4. Company PCL, Inc.